Manufacturer record

Ajanta Pharma Limited: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Ajanta Pharma Limited (Maharashtra) were declared Not of Standard Quality between July 2022 and July 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

1 record linked to Ajanta Pharma Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jul 2022 to Jul 2022

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2022
1
Products affected
Other
Most common failure
Jul 2022
Latest alert

Flagged batches per year

2022 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
CANATE (Antioxidant Tablets with Vitamins and Minerals) CT0771GMfg 2021-07 · Exp 2024-06 Selenium DioxideOther CDL KolkataCDSCO lab Jul 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.